TY - JOUR A1 - Kreiß, Marius A1 - Oberlis, Julia H. A1 - Seuter, Sabine A1 - Bischoff-Kont, Iris A1 - Sürün, Duran A1 - Thomas, Dominique Jeanette A1 - Göbel, Tamara A1 - Schmid, Tobias A1 - Rådmark, Olof A1 - Brandes, Ralf A1 - Fürst, Robert A1 - Häfner, Ann-Kathrin A1 - Steinhilber, Dieter T1 - Human 5-lipoxygenase regulates transcription by association to euchromatin T2 - Biochemical Pharmacology N2 - Human 5-lipoxygenase (5-LO) is the key enzyme of leukotriene biosynthesis, mostly expressed in leukocytes and thus a crucial component of the innate immune system. In this study, we show that 5-LO, besides its canonical function as an arachidonic acid metabolizing enzyme, is a regulator of gene expression associated with euchromatin. By Crispr-Cas9-mediated 5-LO knockout (KO) in MonoMac6 (MM6) cells and subsequent RNA-Seq analysis, we identified 5-LO regulated genes which could be clustered to immune/defense response, cell adhesion, transcription and growth/developmental processes. Analysis of differentially expressed genes identified cyclooxygenase-2 (COX2, PTGS2) and kynureninase (KYNU) as strongly regulated 5-LO target genes. 5-LO knockout affected MM6 cell adhesion and tryptophan metabolism via inhibition of the degradation of the immunoregulator kynurenine. By subsequent FAIRE-Seq and 5-LO ChIP-Seq analyses, we found an association of 5-LO with euchromatin, with prominent 5-LO binding to promoter regions in actively transcribed genes. By enrichment analysis of the ChIP-Seq results, we identified potential 5-LO interaction partners. Furthermore, 5-LO ChIP-Seq peaks resemble patterns of H3K27ac histone marks, suggesting that 5-LO recruitment mainly takes place at acetylated histones.> In summary, we demonstrate a noncanonical function of 5-LO as transcriptional regulator in monocytic cells. KW - 5-lipoxygenase KW - RNA-Seq KW - ChIP-Seq KW - FAIRE-Seq KW - Transcriptional regulation Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/78404 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-784047 SN - 0006-2952 VL - 203 IS - 115187 PB - Elsevier CY - Amsterdam ER -